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Abstract.  ZO-1 is a 210-225-kD peripheral mem- 
brane protein associated with cytoplasmic surfaces of 
the zonula occludens  or tight junction. A  160-kD 
polypeptide, designated ZO-2, was found to coim- 
munoprecipitate with ZO-1 from MDCK cell extracts 
prepared under conditions which preserve protein as- 
sociations (Gumbiner, B., T. Lowenkopf, and D. 
Apatira.  1991. Proc. Natl.  Acad.  Sci.  USA. 88: 
3460-3464).  We have isolated ZO-2 from MDCK cell 
monolayers by bulk coimmunoprecipitation with ZO-1 
followed by electroelution from preparative SDS-PAGE 
gel slices. Amino acid sequence information obtained 
from a ZO-2 tryptic fragment was used to isolate a 
partial eDNA clone from an MDCK library. The 
deduced amino acid sequence revealed that canine 
ZO-2 contains a region that is very similar to se- 
quences in human and mouse ZO-1. This region in- 
eludes both a 90-amino acid repeat domain of un- 
known function and guanylate kinase-like domains 
which are shared among members of the family of 
proteins that includes ZO-1, erythrocyte p55,  the prod- 
uct of the lethal(1)discs-large-1  (dlg) gene of Drosoph- 
i/a, and a synapse-associated protein from rat brain, 
PSD-95/SAP90.  The dlg gene product has been shown 
to act as a tumor suppressor in the imaginal disc of 
the Drosophila  larva, althoug  h the functions of other 
family members have not yet been defined. A poly- 
clonal antiserum was raised against a unique region of 
ZO-2 and found to exclusively label the cytoplasmic 
surfaces of tight junctions in MDCK plasma mem- 
brane preparations, indicating that ZO-2 is a tight 
junction-associated protein. Immunohistochemical 
staining of frozen sections of whole tissue demon- 
strated that ZO-2 localized to the region of the tight 
junction in a number of epithelia, including liver, in- 
testine, kidney, testis, and arterial endothelium, sug- 
gesting that this protein is a ubiquitous component of 
the tight junction. Double-label immunofluorescence 
microscopy performed on cryosections of heart, a non- 
epithelial tissue, revealed the presence of ZO-1 but no 
ZO-2 staining at the fascia adherens,  a specialized 
junction of cardiac myocytes which has previously 
been shown to contain ZO-1 (Itoh, M., S. Yonemura, 
A. Nagafuchi, S. Tsukita, and Sh. Tsukita.  1991. J. 
Cell Biol.  115:1449-1462).  Thus it appears that ZO-2 
is not a component of the fascia adherens,  and that 
unlike ZO-1, this protein is restricted to the epithelial 
tight junction. 
PITnZLIA serve as selectively permeable barriers be- 
tween body compartments.  Free diffusion  of sub- 
stances between epithelial  cells is  prevented  by a 
specialized region of cell-cell contact, the zonula occludens 
or tight junction, which encircles cells at their apices and 
closes the intercellular space (Farquhar and Palade,  1963; 
Diamond, 1977; Gumbiner,  1987). In addition to its sealing 
function, the tight junction plays an important role in polar- 
ization of the epithelial cell surface by preventing mixing of 
membrane lipids and proteins between distinct plasma mem- 
brane domains (Simons and Fuller,  1985). Tight junctions 
Address all correspondence  to Dr. D. A. Goodenough,  Program  in  Cell and 
Developmental  Biology  and Department  of Cell Biology, Harvard Medical 
School, 220 Longwood Avenue,  Boston, MA 02115. 
are dynamic structures, showing differences in permeability 
and structure among different epithelia  (Frtmter and Dia- 
mond, 1972; Claude and Goodenough, 1973), modulation 
under physiologic conditions in response to extracellular sig- 
nals, and rapid assembly and disassembly during morpho- 
genesis, wound healing, and migration of leukocytes across 
endothelia and epithelia (Madam et al., 1992; Schneeberger 
and Lynch, 1992). Although the mechanisms of tight junc- 
tion regulation are not known, protein kinases A and C, to- 
gether with G-protein mediated signaling  pathways have 
been implicated in tight junction assembly and disassembly 
in cultured cells (Balda et al., 1993; Citi, 1992; Balda et al., 
1991; Nigam et al.,  1991). 
The tight junction is visualized by thin section electron mi- 
croscopy as the most apical member of a tripartite junctional 
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adherens in addition to the zonu/a occludens. The tight junc- 
tion is characterized  by a series of membrane contacts at the 
border between the apical and lateral  plasma membranes 
(Farquhar and Palade, 1963) which appear in freeze-fracture 
images as branching and anastamosing  fibrils encircling cell 
apices (Goodenough and Revel, 1970). The junctional fibrils 
are thought  to be composed of rows of integral  membrane 
proteins (Stevenson et al., 1988), although another model of 
tight junction molecular structure has been proposed (Pinto 
da Silva and Kachar,  1982). 
ZO-1 (zonula occladens-1) is a 210-225 kD phosphopro- 
tein which associates  with the cytoplasmic surfaces of the 
tight junction close to the membrane contacts (Stevenson et 
al., 1986; Anderson et al., 1988). ZO-1 has been found as- 
sociated with all tight junctions examined to date, and in two 
additional locations,  adherens junctions in myocardial inter- 
calated  discs  (Itoh  et al.,  1993)  and  cultured  astrocytes 
(Howarth et al., 1992). Recent cloning and sequencing of a 
complete cDNA (Willott et al., 1993; Itoh et al., 1993; Tsu- 
kita et al., 1993) revealed that ZOo1 is a member of  the discs- 
large family of  proteins, including the product of the lethal(l) 
discs-large-1  (dtg) gene of Drosophila (Woods and Bryant, 
1991), erythroeyte p55 (Ruff et al., 1991), and a presynaptic 
junction protein from rat brain (PSD-95/SAP90; Cho et al., 
1992; Kistner et al., 1993). Members of this family contain 
a 90-amino acid internal  repeat domain of unknown func- 
tion, an SH3 (src homology 3) domain, a motif first iden- 
tiffed in the src family of nonreceptor protein  tyrosine ki- 
nases and thought  to mediate protein interactions,  and  a 
guanylate  kinase-like  domain.  Mutations  of the dlg gene 
have been shown to result in neoplastic overgrowth of imagi- 
hal discs,  indicating  that the product of this gene acts as a 
tumor suppressor in Drosophila larvae (Woods and Bryant, 
1989, 1991), although the functions of other family members 
are not known.  The Dlg-A protein has been immunocyto- 
chemically localized to the cytoplasmic surfaces of the sep- 
tate junction (Woods and Bryant,  1991), the arthropod coun- 
terpart of the vertebrate tight junction (Green and Bergquist, 
1982;  Wood,  1990).  Two  other  proteins  have  been im- 
munolocalized to the region of the vertebrate tight junction, 
Cingulin (Mr g  140 kD; Citi et al., 1988) and the 7H6 anti- 
gen (Mr ~  155-170 kD; Zhong et al.,  1993). 
ZO-2, a  160-kD protein,  was identified  as a peripheral 
membrane protein which coimmunoprecipitated  with ZO-1 
from MDCK cell extracts prepared under conditions  which 
maintain  protein associations (Gumbiner et al.,  1991). We 
have obtained amino acid sequence data from purified ZO-2, 
allowing the isolation of  a partial cDNA clone. An antiserum 
was raised against a ZO-2 fusion protein and used to demon- 
strate that ZO-2 colocalizes with ZO-1 at tight junction mem- 
brane contacts,  indicating  that ZO-2 is a component of the 
tight junction. Immunofluorescent  staining of the tight junc- 
tion region was observed in a variety of  epithelial tissues as 
well as in arteriolar endothelium using the ZO-2 antibody, 
suggesting that ZO-2, like ZO-1, is a ubiquitous component 
of the tight junction.  Amino acid sequence comparison of 
ZO-2  with  proteins  in  the  GenbanldEMBL database re- 
vealed that this protein is very similar to, though distinct 
from, ZO-1. ZO-2 also shares sequence homology with other 
members of the discs-large family. These results indicate that 
the tight junction has bound to its cytoplasmic surfaces two 
structurally related and physically associated proteins,  ZO-2 
and ZO-1. Further,  the membrane association  of structural 
homologs at the mammalian tight junction and the arthropod 
septate junction reveals molecular  similarity  between these 
functionally  related intercellular  junctions. 
Materials and Methods 
Reagents 
Tissue culture reagents were purchased from GIBCO BRL (Oaithersburg, 
MD), except for FCS which was obtained from Hyclone Labs. (Logan, 
UT).  Alpha-[32p]dCTP  (>3,000 Ci/mmol) and alpha-[35S]dATP (1,000- 
1,500  Ci/mmol) were from New  England Nuclear (Boston, MA), and 
Tran35S-label was from ICN (Cleveland,  OH). Tntsylol was obtained from 
Miles FBA Division (West Haven, CT). Molecular biological reagents were 
from New England Biolabs (Beverly, MA). All other chemicals were ob- 
tained from Sigma Chem. Co. (St. Louis, MO) unless otherwise specified. 
Cell Culture, Metabolic Labeling, 
and Immunoprecipitation 
Strain II MDCK cells (kindly provided by Dr. Karl Matlin) were grown in 
MEM supplemented with 5% FCS,  100 U penicillin and 100 mg/ml strep- 
tomycin (P/S),  and  10 mM Hepes,  pH 7.3 at 37°C  in a  humidified  at- 
mosphere of 5%  CO2. Cells were metabofically  labeled for 18-24 h at 
37°C  with  150  mCi/ml  Tran35S-label  ([3SS]met/[35Slcys), in  labelin  8 
medium (methionine-free MEM, 5% dialyzed FIBS, P/S, 10 mM Hepas pH 
7.3, supplemented with 10% complete growth medium). At the end of the 
labeling period monolayers  were rinsed twice in ice cold PBS  + (PBS,  1 
mid CaCI2, 0.5 mM MgCI2) and extracted in situ by addition of a modified 
RIPA buffer, designated IP buffer (1% Triton X-100, 0.5%  sodium deoxy- 
cholate, 0.2% SDS,  150 mM NaC1, 2 mM EDTA,  10 mM Ttis, pH 7.4, 
140 K.I.U./ml Tntsylol,  0.01% diisopropyl  fluorophosphate  (DIFP), t 50 
mg/ml benzanfidine,  1 mg/ml chymostatin, 1 mg/ml pepstatin,  1 mg/ml 
leupeptin, and I mM iodoacetic  acid) to the tissue culture plate.  After a 
5-rain incubation on ice,  soinbillzed components were removed from the 
monolayer and fresh IP buffer added for an additional 15 rain. At the end 
of the second incubation, the two extracts were combined and centrifuged 
at 13,000 g for I h at 4°C. Supernatants were immunoprecipitated overnight 
at 4°C with either the rat anti-ZO-1 monoclonal antibody R40.76 (Anderson 
et al., 1988) and rabbit  anti-rat IgG-Sepbarose (Cappel, West Chester, PA), 
or with anti-ZO-2 rabbit polyelonai antiserum R9989 and protein A-Seph- 
arose (Siorna Chem. Co.). The following antibodies were used in control 
immunoprecipitations: the negative control for R40.76 was  R5.21,  a  rat 
monoclonal of the same isotype as R40.76 that is directed against gap junc- 
tion connexin32 (Stevenson et al., 1986). R9989 preimmtme serum served 
as the negative control for R9989.  R40.76 and R5.21 culture supernatants 
(C.S.)  were used for immunoprecipitations at a concentration of 0.4 ml 
C.S./ml extract,  whereas the R9989 immune and preimmtme anti,sent were 
diluted 80-fold with hybridoma  growth medium (Stevenson et al., 1986) be- 
fore addition to the cell extract (400 ml/ml extract).  30 ml of a 1:1 slurry 
of  conjugated Sepharose beads were used per ml of extract. Immunoprecipi- 
tates were washed with IP buffer three times, once with 0.5 M NaCl,  10 
mM Tris, 2 mM EDTA, pH 7.4, and finally with 10 mM Tris, 2 mM EDTA 
pH 7.4. After denaturation in SDS sample buffer by boiling for 5 rain in 
the presence of/~-mercaptoethanol, immunoprecipitates were analyzed by 
7.5%  SDS-PAGE and fluorogntphy. 
ZO-2 Purification and Amino Acid Sequencing 
A total of 100 miler bottles (1585 em2/bottle;  Bellco,  Vineland, NJ) of 
confluent MDCK cells were used for the isolation of ZO-2; 10 bottles were 
processed at a time. Bottles were rinsed two times each with 50 ml of ice 
cold PBS  + and scraped up in 15 ml/botfle of 4oC IP buffer. The cell ex- 
tracts were spun at 1,300 g for 60 rain at 4*(2 and supernatants/mmunopre- 
cipitated with R40.76 and rabbit anti-rat-Sepharose as described above to 
isolate ZO-I/ZO-2 complexes.  ProTeins were eluted from Sepbarose beads 
by boiling in '~,1.5 times the packed bead volume of SDS sample buffer 
1. Abbreviations used in this paper: DHR, discs-larga  homology region; 
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of 100 roller bottles were thawed,  passed through 0.2-ttm filter (Nalgene, 
Rochester,  NY),  concentrated flvefold by ultrafiltratiou  (Centrieon 100; 
Amicon, Beverly, MA), and run on five 0.75 nun 7.5% preparative SDS- 
polyacrylamide  gels to separate ZO-2 from contaminating proteins.  Gels 
were stained with 0.25 M KCI at 40C, after which the ZO-2 bands were 
excised,  and protein electroeluted into dialysis tubing (Spectrum Medical 
Industries, Inc., Los Angeles, CA) in the presence of 0.5%  SDS, 2 m_M 
ElYrA,  40 mM Tris  Acetate,  pH 8.6. The eluate ('~23 ml) was passed 
through a 0.2-ttm filter, concentrated 20-fold by ultrafiltration, and brought 
to a final concentration of 20% methanol, 0.003 % bromophenol blue, and 
4 % ultra pure sucrose.  The elnate was then electroblotted onto nitrocellu- 
lose (Sehleieher and Schuell,  Keene, Nil) using a custom-made apparatus 
composed of upper (cathode) and lower (anode) buffer chambers separated 
by nitrocellulose and filled with 0.1% SDS, 20% methanol, 2 mM EDTA, 
40 mM Tris acetate buffer, pH 8.6. The sample was loaded in the bottom 
of the upper chamber and 100 V were applied until the dye passed through 
the nitrocellulose to the lower chamber, about 30 rain. Approximately  70 
pmol of ZO-2 protein on 37 mm  2 nitrocellulose were submitted to the Hat- 
ward Mieroehemistry Facility  (Harvard University,  Cambridge, MA) for 
trypsin digestion and amino acid sequencing as described by Aebersold et 
al.  (1987) and Lane et al.  (1991). The following  amino acid sequences 
were obtained from two different tryptic polypeptides:  LAGGNDVGIFVA- 
GIQEGTSAEQEGL was  obtained from the first tryptie fragment with 
high  confidence;  LISDFEDT(D)GE(G)(G)AYTDNELD(E)P(A)(E)  was 
obtained from the second fragment (parentheses indicate residues  deter- 
mined with lower confidence). 
Screening of  a  cDNA Library 
A nondegenerate ZO-2 hybridization probe was produced using PCR. De- 
generate oligonucleotide  primers were made corresponding to the NH2 ter- 
minus (5'-GCX GGX GGX AAC/T GAC/T GT-3') and COOH terminus (3'- 
CGX  CTC/T  GTC/T  CTC/T  CCX  A/GA-5')  of  the  amino  acid  se- 
quence,  AGGNDVGIFVAGIQEGTSAEQEGLR,  obtained from direct se- 
quencing of a ZO-2 tryptic polypeptide (see above).  The template for the 
reaction was eDNA made by reverse transcription of MDCK total RNA ac- 
cording to the method of Sambrook et al. (1989); RNA was isolated from 
confluent MDCK cells by the guanidium isothyoeyante/CsCl  method of 
Sambrook et al. (1989). A 72-bp PCR product resulting from this PCR am- 
plification was subcioned into the ECORV site of pBlneseript II SK  + to pro- 
duce the plasmid p6, and sequenced on both strands (Sequenase,  Un. States 
Biochemical, Cleveland, OH) to confirm that it encoded the amino acid se- 
quence of the 7_,0-2 tryptic fragment. To prepare probe, plasmid p6 was 
digested  with XbaI and XhoI and an "o140 bp fragment containing ZO-2 
coding sequence was isolated and random-prime labeled with [32p]dCTP 
according to manufacturer's instructious (Boehringer Maunheim Corp., In- 
dianapolis,  IN). This labeled probe was then used to screen an oriented 
oligo(dT)-primed MDCK eDNA library in X-ZAP (kindly provided by Dr. 
Marino Zeriai) using the method of Sambrook et al. (1989). Twelve posi- 
tively hybridizing  phage were isolated after screening of,~500,000 plaques. 
pBlueseript  was  excised  from  pleqne-purified  phage  according  to  the 
manufacturer's  instructions (Stratagene,  La Jolla,  CA)  and the longest 
insert, 3.2 kb, contained in the plasmid pB6C,  was subjected to double- 
stranded sequencing (Sequenase,  see above or TaO'rack, Promega, Madi- 
son, WI). This partial sequence is available from the GenBank/EMBL data- 
base under accession #L27152. 
Sequence Analysis 
Amino acid sequences were compared using the GAP alignment program 
in the University of Wisconsin Genetics Computer Group Software Pack- 
age. The internal repeat domains of ZO-2 (amino acids 96-176) and mouse 
7_£)-1 (amino acids 423-503) were compared with each other and those of 
Dlg-A (amino acids 486-566, third repeat), PSD-95 (amino acids 313-393, 
third repeat), and p55 (amino acids 92-149). The putative SH3 regions of 
ZO-2 (amino acids 193-246) and ZO-I (amino acids 520--576) were com- 
pared with each other and with those of DIg-A (amino acids 604--622), 
PSD-95  (amino acids 432-495),  and p55  (amino acids  162-225).  The 
guanylate kinase domains of ZO-2 (amino acids 315-466) and ZO-I (amino 
acids 644-794) were compared with each other and with those of Dig-A 
(amino acids 770--948),  PSD-95 (amino acids 534-712), and p55 (amino 
acids 282-454).  Default alignment parameters of the Gap program were 
used to determine percent identity and percent similarity of sequences being 
compared. Sequences were obtained from the GenBank/EMBL and Protein 
Identification Resource  data bases. 
Northern  Analysis 
Total RNA was isolated from MDCK cells by the one-step method of Au- 
subel et ai.  (1992).  Poly(A) + RNA was  isolated from total RNA using 
the PolyATtract mRNA Isolation System Ill kit (Promega).  RNA transfer 
was performed as described previously (White et al.,  1992).  A 725-bp 
EcoRlJPstI restriction  fragment generated from a buma~l ZO-1 eDNA clone 
(kindly  provided by Dr.  L  M.  Anderson) was random prime-labeled to 
generate a ZO-I probe. A ZO-2 probe was made by PCR amplification  of 
nucleotides  2-850 of the pB6C insert (see above)  and random priming. 
Blots were hybridized and washed as described by White et al. (1992) except 
that the ZO-1 blot vats washed for an additional 10 rain at 650C in fresh 
1% SDS, 0.3 M sodium phosphate, pH 7.2 buffer whereas the blot probed 
with ZO-2 was washed for an additional 30 rain in 15 mM sodium phos- 
phnte,  pH 7.2, 0.05%  SDS at 65"C. 
Antibody Production 
Antibodies were raised against a glutathione S-trausferase  (GST)/ZO-2 fu- 
sion protein. To construct the fusion protein, nucleotides 2-295 of the pB6C 
insert were PCR-amplified  and subcloned into the EcoRI-BamHI sites of 
the expression vector pGEX-2T (Smith and Johnson, 1988). Expression of 
fusion protein and isolation by affinity chromatography on immobilized 
glutathione were performed as described in Smith and Johnson (1988). Rab- 
bits and guinea pigs were immunized by popllteai lymph node injection 
using 50 mg protein/injection (Focono Rabbit Farm and Laboratory, Can- 
dadeusis, PA). Crude serum from rabbit R9989 and guinea pig GF'/53 were 
used for immunoblots and immunoprecipitations. For immunocytochemis- 
try, the R9989 antiserum was affinity purified on a fusion protein-Sepharose 
4B (Pharmacia LKB, Uppsala, Sweden) column. 
Immunoblotting 
MDCK whole cell extracts were prepared by rinsing monolayers  with ice 
cold PBS  +, scraping in IP buffer, and boiling, in 1/10 vol 10× SDS sample 
buffer with/~-mercaptoethanol. Proteins were separated by SDS-PAGE on 
either 6% mitosis or 7.5%  standard gels and electrophoretieally  trans- 
ferred (Towbin et al., 1979) onto Immobilon (Millipore Corporation, Bed- 
ford, MA). Incubation of blots with antibodies was carried out as described 
previously (Stevenson et al., 1986). Culture supernatants of R40.76 (Ander- 
son et al.,  1988)  were used undiluted; the pulyclonal  antisera R9989, 
GP753, and rabbit anti-cingulin (generously  provided by Dr. S. Cifi) were 
used at 1:2,500,  1:500, and 1:5,000, respectively.  Alkaline phosphatase- 
conjugated  secondary antibodies (anti-rabbit IgG, Pmmaga; anti-rat IgG, 
Pierce,  Rockford,  IL)  and  HRP-conjngated  goat  anti-gninea pig  IgG 
(Chemicon, Co., Temecula, CA)were used at 1:5,000, 1:2,000, and 1:500, 
respectively. 
Immunofluorescence and lmmunoelectron Microscopy 
Double-label immunofluorescence  microscopy  was performed with con- 
fluent MDCK cells grown on glass coverslips.  Cells were  rinsed with 
PBS  +, fixed for 10 rain at room temperature in 2% paraformuldehyde  in 
PBS  +,  and permeabilized in 0.2%  Triton X-100-containing  PBS.  Cells 
were then incubated sequentially with R40.76 culture supernatant, affinity- 
purified R9989 diluted 1:20 in PBS containing 5% normal goat serum, and 
a mixture of FITC-conjugated  goat anti-rat IgG (Cappel) and rhodamine- 
conjugated  goat anti-rabbit IgG (Pierce). After staining, samples were 
mounted with 60% glycerol, 0.4% n-propyl galate in PBS. Frozen sections 
of various unfixed canine tissues (kindly provided by Dr.  "lkichi Takeda) 
were prepared for immunofluorescence  as described previously (Stevenson 
et al., 1986). Heart sections were double-labeled as described for MDCK 
cells, exxept that the secondary antibodies were adsorbed with heart plasma 
membranes (Paul  and Goodenough,  1983) before use to eliminate non- 
specific staining.  All other tissue sections were stained with R9989 using 
rhodamine-conjugated goat anti-rabbit IgG as  the secondary antibody. 
Epifluorescence microscopy was performed with a Zciss Axinskop  and pho- 
tographed with either Tmax 400 or Ektar 1000 film. 
For immanngold electron micmacopy,  membranes were prepared by 
homogelnizln~ four 10-era plates of confluent MDCK cells with 15 strokes 
in a 7-ml Doance tissue homogenizer (Bellco Glass, Inc.) in ice-cold 1 mM 
NaI-ICO3, pH 8.0, containing the protease inhibitors 2.5 mg/ml leupeptin, 
0.5 mg/ml pepstatin, 0.5 mg/ml chymostatin, 0.01% DIFP,  140 K.I.U./ml 
Trasylol,  and 1 mM DTT. Protease inhibitors were used in all subsequent 
buffers and antisera. The homogenate was spun at 1,500 g for 10 rain at 40C 
to pellet membrane sheets. The pellet was resuspended in 0.1% BSMPBS 
Jesaitis and Goodenough Characterization of ZO-2  951 and incubated for 10 rnin on ice to block  non-specific  binding of anfisera. 
The membrane  sheets were then incubated overnight at 4"C in either un- 
diluted R40.76 culture supernatant or in undiluted affinity-purified  R9989 
in 0.1% BSA/PBS. Membranes  were washed, incubated  in the appropriate 
undiluted pre,  adsorbad (Gmijters  et el., 1987) 5-rim  gold-conjugated sec- 
ondary antibodies (Goat  anti-rat lgG or goat anti-rabbit  IgG; Janssen  Life 
Sciences Products, Piscataway,  NJ) and processed  for electron microscopy 
as described previously (Stevenson  et al., 1986). 
Results 
Isolation of  ZO-2 
Lane 1 of Fig. 1 demonstrates that the anti-ZO-1 monoclonal 
antibody R40.76 coimmunoprecipitated ZO-2 from metabol- 
ically labeled MDCK cell extracts prepared with a mixture 
of Triton  X-100,  deoxychoiate,  and  SDS  (modified RIPA 
buffer).  ZO-2  was  not  observed in  immunoprecipitations 
performed using a control monoclonal antibody (lane 2). A 
specific  130-kD polypeptide (arrowhead,  Fig.  1) was also 
seen in ZO-1 immunoprecipitates, but the level of this pro- 
tein varied greatly between different experiments. To deter- 
mine whether the R40.76  monoclonal recognized ZO-2, an 
3sS-labeled  ZO-1/ZO-2  coimmunoprecipitate  identical  to 
that in lane 1 Was boiled in SDS and/3-mercaptoethanol to 
dissociate  proteins,  diluted  in  a  Triton  X-100  containing 
buffer to create conditions compatible with antibody-bind- 
ing, and re-immunoprecipitated with R40.76.  As shown in 
lane 3, although ZO-1 was immunoprecipitated after denatu- 
ration with SDS, the 16O-kD polypeptide was not detected, 
demonstrating that ZO-2 did not contain the R40.76 epitope. 
These results are in keeping with those of Gumbiner et al. 
(1991) who have previously shown that anti-ZO-1 antibodies 
do not react with coimmunopreeipitated ZO-2 in a Western 
blot after SDS-PAGE. 
R40.76  was  used  to  purify  ZO-2  by  bulk  coimmuno- 
precipitation of MDCK cell extracts followed by prepara- 
tive SDS-PAGE and excision and electroelution of the ZO-2 
band.  Fig.  2  shows  a  Coomassie blue-stained  gel  of the 
bulk eoimmunoprecipitate (lane/) and ,,o0.1 and 0.5 pmoles 
(lanes 2 and 3, respectively) of the gel-isolated ZO-2 protein. 
Approximately  70  pmol  of  purified  ZO-2  was  directly 
blotted  onto  nitrocellulose  and  submitted  to  the  Harvard 
Microchemistry  Facility  for  trypsin  digestion  and  amino 
acid  sequencing.  Sequence  data  were obtained  from two 
ZO-2 tryptic fragments (see boxed regions, Fig. 4). The se- 
quence from the first fragment was determined with a high 
degree of certainty over 25 amino acid residues and thus was 
used to clone a  eDNA for ZO-2. 
ZO-2 Is Related to ZO-I and the Discs-Large Tumor 
Suppressor Protein 
Degenerate oligonucleotide primers based on the NH2- and 
COOH-termini of the amino acid  sequence  from the  first 
Figure  1.  ZO-2  coimmanoprecipitates  with  ZO4.  Confluent 
MDCK cell monolayers were metabolically labeled with [35S]me- 
thionine/cysteine  overnight,  extracted  with  0.5%  Triton  X-100, 
0.5% deoxycholate, 0.2% SDS, and immunoprecipitated with anti- 
7_.O-1 monoclonal antibody R40.76 (lane 1 ) or a control monoclonal 
antibody of the same isotype (lane 2), followed by rabbit anti-rat 
conjugated Sepharose. Immunoprecipitates were analyzed by SDS- 
PAGE and fluorography. Both ZO-1 and 7,0-2 are seen in the coim- 
mtmoprecipitate in lane 1 together with an Mr ~  130 kD band (ar- 
rowhead).  A 3sS-labeled coimmtmoprecipitate identical to that in 
lane I was boiledin 2% SDS to dissociate the ZO-1/ZO-2 complex 
and  reimmunoprecipitated  with  the  R40.76 antibody  (lane  3), 
yielding only ZO-1. Molecular  weights of protein  standards  are 
given in kiloDaltons  (kD). 
Figure 2.  Isolation  of ZO-2 from MDCK cells.  ZO-2 was bulk- 
coimmtmoprecipitated from MDCK cells and isolated on prepara- 
tive  SDS  polyacrylamide  gels  as  described  in  Materials  and 
Methods.  Lane 1 shows a Coomassie brilliant  blue-stained  poly- 
acrylamide  gel of the bulk-coimmtmoprecipitate.  Lanes 2  and 3 
show gel-isolated  ZO-2  at 0.1  and  0.5  pmol estimated  loading 
amounts, respectively. Molecular weight standards are given in kD. 
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PCR reactions containing MDCK eDNA. A 72-bp product 
was amplified and subcloned into pBluescript for DNA se- 
quencing. The deduced amino acid sequence matched that 
of the ZO-2 tryptic fragment. The 72-bp product was used 
to screen an MDCK eDNA library in k-Zap under stringent 
conditions. A 3.2-kb clone was isolated and sequence analy- 
sis showed that it included  both previously generated internal 
amino acid sequences of ZO-2 (see boxed residues, Fig. 3). 
We conclude that the 3.2-kb ZO-2 clone is not a full length 
cDNA. The nucleotide sequence did not contain a consensus 
initiation codon as defined by Kozak (1989).  In addition, a 
single open reading frame beginning at the second nucleo- 
tide was found to encode 775  amino acid residues with a 
predicted molecular mass of 86.9 kD, significantly less than 
the Mr ~  160 kD observed on SDS gels. Northern analysis 
(presented below) further supported our conclusion that the 
clone is a partial eDNA. The presence of a poly(A)  + tail, 
preceded by a polyadenylation signal in the 3' noncoding re- 
gion of  the clone, indicated that this cDNA encodes carboxy- 
terminal amino acid residues. 
A  search of the GenBanldEMBL protein data base re- 
vealed strong similarity between ZO-2 and ZO-1 from both 
mouse (54% identical; Itoh et al., 1993) and human (49% 
identical; WiUot et al., 1993).  Mouse and human ZO-1 are 
88%  identical over their entire length.  Alignment of the 
predicted carboxy-terminal amino acid sequences of ZO-2 
and  mouse  ZO-1 (Fig.  3)  revealed  that  ZO-2  exhibited 
greatest similarity with ZO-1 (~70% identical from residue 
96 to 541 of ZO-2) in a region previously shown to share se- 
quence homology with members of the discs-large family of 
proteins (DIg-A, PSD-95/SAP90, p55; WiUot et al., 1993). 
The  sequence  homologies  of these  family members  are 
clustered in several domains, including a  novel 90-amino 
acid internal repeat region (disc-large homology region, or 
DHR) of unknown function (Cho et al., 1992),  an SH3 do- 
main (Musacchio et al., 1992), and a region similar to yeast 
guanylate kinase (Berger et al.,  1989).  While there are up 
to three internal repeat (DHR) domains in members of the 
discs-large family, the available sequence for ZO-2 contains 
a single DHR domain which is most closely related to the 
third internal repeat.  The close relationship exhibited be- 
tween ZO-2 and ZO-1 indicated that the former was also a 
member of the discs-large family of proteins. 
The region of  high similarity between ZO-2 and ZO-1 also 
encompassed sequences not shared by other members of the 
discs-large family, including an acidic domain (Willot et al., 
1993) and a heptad repeat of leucine residues 0toh et al., 
1993), characteristic of the leucine zipper-type dimerization 
motif (Landschulz et  al.,  1988).  Another feature shared 
uniquely by ZO-2 and ZO-1 was a proline-rich carboxyl ter- 
minus (13 % from residue 560 of ZO-2, 14.4 % from residue 
883 of ZO-1; Willot et al., 1993). These carboxy-terminal se- 
quences, however,  displayed significantly less similarity to 
each other (~ 33 % identical from residue 528 of Z O-2) than 
the preceding domains. ZO-1 has been shown previously to 
contain  an  alternatively  spliced  80-amino  acid  domain, 
designated a-motif (see Fig. 3, v~rtllot  et al., 1992). It is not 
possible to determine from the amino acid sequence align- 
ment alone whether ZO-2 also has an u-motif. 
Direct comparison of amino acid sequences indicated that 
ZO-2 is also related to other members of  the discs-large fam- 
ily (Table I). ZO-2 is most closely related to ZO-1, but also 
displayed homology to  Dlg-A  and PSD-95.  The greatest 
identity between these proteins was found in the region of  the 
third internal repeat and guanylate kinase domains.  Less 
identity is shown between the SH3 domains of either Dlg-A 
or PSD-95 and ZO-2, though the relatively high level of con- 
served amino acid residues suggests a possible evolutionary 
relationship. 
Northern analysis suggested that the 3.2-kb clone is a par- 
tial eDNA and revealed that ZO-2 and ZO-1 are encoded by 
distinct messenger RNAs in MDCK cells. Under stringent 
conditions, a ZO-2 probe hybridized to a single band of 5.2 
kb in both total and poly(A)  + RNA prepared from MDCK 
cells (Fig. 4, lanes I and 2). In contrast, the ZO-1 probe hy- 
bridized to a 7.9 kb species (lane 3), similar in size to that 
previously reported for human (Anderson et al., 1989) and 
rodent ZO-1 (Howarth et al.,  1992;  Itoh et al.,  1993). 
ZO-2 Antibodies Coimmunoprecipitate ZO-1 
To generate an antiserum specific for ZO-2, a fragment of 
the 3.2-kb  clone encoding sequences displaying the least 
similarity to ZO-1 (amino acids 1-88) was fused to the gene 
encoding GST.  Fusion protein isolated on GST-eonjugated 
Sepharose was used to immunize rabbits, resulting in the 
polyclonal antiserum R9989.  In Fig. 5, an anti-ZO-1  coim- 
munoprecipitate containing ZO-1 and ZO-2 proteins (lanes 
1,  3,  and 5,  labeled "Ip") and a whole MDCK-cell extract 
(lanes 2, 4, and 6, labeled "E"), were run on an SDS-PAGE 
gel, transferred to Immobilon, and reacted with either anti- 
ZO-2,  anti-Cingulin, or  anti-ZO-1  antibodies.  The poly- 
clonal antiserum R9989 recognized ZO-2 as a Mr ~  160 kD 
band in the coimmunoprecipitate but not the Mr ~  210 kD 
ZO-1  (lane /).  In the whole cell extract,  a  doublet at Mr 
160 kD was observed in addition to a faint band at Mr 
190 kD (lane 2). Anti-eingulin antiserum (the generous gift 
of S. Citi) recognized a Mr ---- 140 kD band in whole cell ex- 
tracts (lane 4) which was not detectable in the immunopre- 
cipitates (lane 3), while anti-ZO-1  labeled the Mr --- 210 kD 
protein in both specimens (lanes 5 and 6). These data dem- 
onstrated that ZO-2 was immunologieally  distinct from both 
cingulin and ZO-1, and suggested that cingulin was not asso- 
ciated with the ZO-2/ZO-1 complex in MDCK cell extracts. 
In  a  reciprocal  experiment,  the  R9989  antiserum was 
demonstrated to coimmunoprecipitate ZO-1 with ZO-2 from 
MDCK extracts. Metabolically labeled MDCK cell extracts 
were prepared in the Triton X-100, DOC,  SDS detergent 
mixture to preserve protein interactions and immunoprecipi- 
tated with either the anti-ZO-1 monoclonal or the anti-ZO-2 
R9989  polyclonal.  As  shown previously,  both  ZO-1 and 
ZO-2 were immunoprecipitated by the ZO-1 antibody (Fig. 
6, lane/). Bands comigrating with ZO-1 and ZO-2 were ob- 
served when the anti-ZO-2 antibody was used for the immu- 
noprecipitation (lane 3). Positive identification of  these poly- 
peptides was made by immunoblot analysis of the R9989 
coimmunoprecipitate using either rat anti-ZO-1  or guinea 
pig anti-ZO-2 antibodies (Fig. 6, lanes 5 and 6); guinea-pig 
anti-ZO-2 antiserum (GP'/53) was used for the immunoblot 
in lane 6 to avoid staining of the rabbit immunoglobulin 
(R9989) used for the coimmunoprecipitation by the alkaline 
phosphatase-conjugated secondary antibodies. In lane 3, two 
additional bands at M~ ~  180 and 240 kD were observed in 
the R9989 coimmunoprecipitate. The absence of these poly- 
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Figure 3. Comparison of ZO-2 and ZO-I predicted amino acid sequences. A vertical line indicates identity, two dots a conservative amino 
acid change,  and one dot a less conservative  change.  ZO-2 tryptic fragment sequences  are boxed.  The third internal repeat (DHR) is 
identified with a thin solid line; SH3 domain, with a thin dashed line; guanylate kinase domain, with a thick solid line; acidic domain, 
with a dotted line; alternatively spliced tx-motif of ZO-1, with two thin solid lines. The four leucine residues of the leucine zipper motif 
are marked by ar~wheads. The ZO-2 cDNA sequence data are available from EMBL/GenBank DDB.I under accession number L27152. 
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of Proteins 
ZO-2  ZO-  1 
ZO-1  69 (86)  100 
dig  37 (63)  41  (69)  Internal 
PSD-95  39 (64)  43  (67)  repeat 
p55  16 (43)  27 (54) 
ZO-1  70 (87)  100 
dig  17 (59)  28 (60)  SH3 
PSD-95  26 (56)  39 (61)  domain 
p55  19 (50)  29 (58) 
ZO-1  67 (83)  100 
dig  27 (50)  32 (54)  GK 
PSD-95  32 (51)  27 (55)  domain 
p55  22 (51)  26 (49) 
Amino acid residues contained in the internal ~t,  SH3, and guanylate 
kinase domains of ZO-2 and ZO-1 were compared  with those of other discs- 
large family  members.  Percent  identity and percent similarity  (percent  identical 
residues plus conservative  substitutions, in parentheses)  were calculated using 
the  GAP alignment program, based on the algorithm of Needleman and 
Wunsch (1970). The residues compared  are given in Materials and Methods. 
peptides  in both the anti  ZO-1  immunoprecipitate  (lane/) 
and in a  coimmunoprecipitate  performed using  the guinea 
pig  anti-ZO-2  fusion  protein  antiserum  (GP'/53,  data  not 
shown)  makes  it  unlikely  that  the  Mr  ~  180  and  240  kD 
bands are polypeptides associated with ZO-1/ZO-2 complex. 
Z0-2 Is a Component of the 1ight Junction 
The cellular distributions of ZO-2 and ZO-1 were compared 
by double-label immunofluorescence microscopy in conflu- 
ent MDCK cell monolayers ('Fig. 7).  ZO-1 (left panel) and 
ZO-2  (right panel)  colocalized  at the  apical  cell  borders, 
resulting in indistinguishable,  honeycomb-like staining pat- 
terns. The afffinity-purified anti-ZO-2 antibodies also showed 
some diffuse  cytoplasmic  staining  not  observed  for ZO-1. 
Both the cytoplasmic and cell border staining seen with the 
anti-ZO-2 antibodies could be competed with ZO-2/GST fu- 
sion protein but not with GST alone (data not shown). 
Figure 4. Northern blot analy- 
sis.  10/~g of total RNA iso- 
lated from confluent  MDCK 
cells  were  loaded  in  lane  1. 
Lanes  2  and  3  each  con- 
tain  2.5  /~g  of  MDCK 
poly(A)  + RNA. A 7-.0-2 probe 
hybridized to a ,,o5.2-kb tran- 
script  in  both  total  and 
poly(A)  + RNA  (lanes  1  and 
2). A 7.9-kb transcript was de- 
tected in poly(A)  + RNA using 
a human ZO-1 probe (lane 3). 
The  positions  of RNA  stan- 
dards  are  indicated  in  kilo- 
bases. 
Figure 5.  Immunoblot  analysis  of whole  cell  extracts  and  the 
ZO-1/ZO-2 immunoprecipitated  complex with  various  antisera. 
Anti-ZO-1  coimmunoprecipitate (lanes 1,  3,  and 5,  labeled "Ip,  ~ 
prepared as in Fig. 2, lane/) and whole MDCK cell extract (lanes 
2,  4,  and 6, labeled ~E,  ~ prepared as described in Materials and 
Methods) were subjected to SDS-PAGE, electroblotted onto Im- 
mobilon, and reacted with the following antisera: (Lanes I  and 2) 
anti-ZO-2 fusion protein polyclonal R9989;  (lanes 3 and 4) anti- 
cingulin polyelonal antiserum; (lanes 5 and 6) anti-ZO-1  monoclo- 
hal R40.76.  Molecular weight standards are given in kD. 
Immunogold electron microscopy was used to determine 
the ultrastructural localization of ZO-2. Plasma membranes 
isolated from confluent MDCK cells were used to permit ac- 
cessibility of the antibodies to the cytoplasmic surfaces of the 
tight junction.  Fig.  8 shows electron micrographs of plasma 
membrane pairs labeled  with either anti-ZO-1  monoclonal 
antibody  (upper panel)  or  afffinity-purified  R9989  (lower 
panel).  5-urn  gold-conjugated  secondary  antibodies  were 
used to detect the primary antibodies.  The labeling patterns 
observed  for 7_£)-1 and  ZO-2  were  indistinguishable.  The 
gold particles clustered along the cytoplasmic surfaces of the 
tight junction,  which is seen as closely apposed regions of 
plasma membrane proximal to other members of the junc- 
tional  complex,  and  were  absent  from  other  areas  of the 
membranes. 
Z0-2 Is Present in a Variety of  Epithelia 
and in Endothelia 
Affinity purified P.,9989 antibodies were used to examine the 
distribution  of ZO-2 in a  number of different epithelia.  In- 
tense staining of  junctional complexes was observed in liver, 
Jesaitis and Goodenough Omracterization  of  ZO-2  955 Figure 6. Coimmunoprecipitation of ZO-I using anti-ZO-2 fusion 
protein serum.  Lanes 1-4 show fluorographs of immunoprecipi- 
tates of MDCK extracts performed with different antibodies. (Lane 
1), anti-ZO-1 monoclonal antibody R40.76; (lane 2)control mono- 
clonal antibody of the same isotype as R40.76; (lane 3) anti-ZO-2 
fusion protein serum R9989; (lane 4) R9989 preimmune serum. 
Lanes 5 and 6 show immunoblots of an R9989 immunoprecipitate, 
identical to that shown in lane 3, reacted with either anti-ZO-1 
monoclonal R40.76 (lane 5) or guinea pig anti-ZO-2 fusion protein 
GP753 (lane 6). 
intestine,  kidney,  and  testis  (Fig.  9).  Junctional  complex 
staining between adjacent bepatoeytes (a) appeared as pairs 
of dots (arrows) and continuous lines (arrowhead) on either 
side of  the bile canaliculi as has been described for anti-ZO-1 
staining  (Stevenson et al.,  1986).  In intestinal epithelium 
(b), ZO-2 localized to the junctional complexes (arrows) ad- 
jacent to the intestinal lumen (L) along both the villi and 
crypts (C).  Diffuse cytoplasmic staining  seen in intestine 
resulted from non-specific binding of secondary antibodies 
on the frozen section (data not shown).  Cross-sections of 
kidney tubules (c) revealed staining at the apical-most lateral 
borders of both proximal and distal tubule epithelial cells. 
In cryosections of testis (d), the distinctive staining pattern 
of Sertoli-Sertoli cell junctions (arrowheads) was observed 
in seminiferous tubules (T) and bright dots of fluorescence 
appeared between contiguous medal endothelial cells (A). 
Thus ZO-2 is present in the junctional region of all epithelia 
examined in this study. 
Previous  studies  revealed  that  ZO-1  immunoreactivity 
localizes to the fascia adherens,  a specialized intercellular 
junction, unrelated to the tight  junction, that plays a cohesive 
role between opposing ends (intercalated discs) of cardiac 
muscle cells (Itoh et al.,  1993). Double-label immunofluo- 
rescence microscopy was performed on cryosections  of  heart 
to examine the relative distributions of ZO-1  and ZO-2 in 
cardiac tissues.  Prominent ZO-1  staining  (Fig.  10,  upper 
panel) was seen in both blood vessels (arrows) and interca- 
lated discs (arrowheads). In contrast, ZO-2 was localized ex- 
clusively in blood vessels (arrows, Fig.  10,  lower panel), 
demonstrating that although ZO-1 and ZO-2 colocalize  in en- 
Figure  7.  ZO-1 and  ZO-2 
colocalize to apical cell bor- 
den in the MDCK epithelial 
cell  line.  Cells  grown  on 
glass  were  fixed with  para- 
formaldehyde, permeabilized 
with Triton X-100, and stained 
with  a  mixture  of anti-ZO-I 
monoclonal  R40.76 and  af- 
finity-purified anti-ZO-2  fu- 
sion protein polyclonal R9989. 
Both  ZOq  (le~ panel) and 
ZO-2 (rightpanel) delineate a 
thin band around cell apices. 
Diffuse ZO-2 immunoreactiv- 
ity was also se¢n in the cell 
cytoplasm. Bar, 20 #m. 
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localize to the tight junction in 
isolated MDCK plasma mem- 
branes.  5-nm  gold  particles 
coupled to the secondary im- 
mune  reagents  were  seen 
along  the  cytoplasmic  sur- 
faces of fight junctions using 
either R40.76  monoclonal  (anti- 
ZO-1, upper  panel) or R9989 
polyclonal serum  (anti-ZO-2 
fusion protein, lower  panel). 
Maculae  adhaerentes (MA) 
are  not  decorated  with  the 
gold label. Bar, 100 nm. 
dothelial tight junctions, they are not obligate partners in the 
fascia adherens. 
Discussion 
We have shown that ZO-2, a 160-kD polypeptide associated 
with ZO-1 in MDCK cell detergent extracts, is a component 
of the tight junction. Ultrastructural localization performed 
on plasmamembranes isolated from confluent MDCK cells 
demonstrated that ZO-2 was associated with the cytoplasmic 
surfaces of the tight junction membrane.  Immunofluores- 
cence microscopy revealed that  ZO-2  was  present in  the 
junctional complexes of a number of different epithelia and 
in endothelia, suggesting that this protein, like ZO-1,  is a 
ubiquitous component of the tight junction. 
The partial eDNA clone we obtained codes for ZO-2 pro- 
tein based on two criteria. First, the 3.2-kb clone encoded 
the amino acid sequences obtained from two ZO-2 tryptic 
fragments. Second, antibodies prepared against a GST/ZO-2 
fusion protein recognized ZO-2 by immunoblot analysis and 
immunoprecipitation.  Comparison  of the  deduced amino 
acid sequence with those contained in the GenBank/EMBL 
data base revealed that ZO-2 was closely related to, but dis- 
tinct from, ZO-1. ZO-2 was also found to exhibit homology 
to other members of the discs-large family of proteins, par- 
ticularly with the Dlg-A protein of Drosophila  and PSD- 
Jesaitis and Goodenough Characterization of ZO-2  957 Figure 9. Immunofluorescent localization of ZO-2 frozen sections of liver, intestine, kidney, and testis. (a) Liver. ZO-2 localized to the 
junctional complexes of hepatocytes. Pairs of dots (arrows) were observed flanking bile canaliculi in cross section, while parallel lines 
were seen in longitudinal views (arrowhead). (b) Intestine. Dots of fluorescence were observed between enterocytes (arrows) adjacent to 
the intestinal lumen (L) along both the villi and crypts (C). (c) Kidney. Junctional complexes were stained in cross sections of kidney 
tubules which appeared either as dots (arrow) or continuous lines (arrowhead). (d) Testis. ZO-2 localized within Sertoli-Sertoli  ceil junc- 
tions (arrowheads) in the seminiferous epithelium of two seminiferous tubules (7"). The endothelial  junctions of an arteriole (A) also show 
ZO-2 immunoreactivity. Bar, 20/~m. 
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munofiuorescent localization 
of ZO-1 and ZO-2 in frozen 
sections  of  heart.  Unfixed 
cryosections were stained si- 
rnultaneously  with  R40.76 
(anti-ZO-1, upper  panel) and 
R9989  (anti-ZO-2,  lower 
panel) followed by FITC-goat 
anti-rat  (to  visualize ZOq) 
and rhodaminv-goat  anti-rabbit 
(to visualize ZO-2). ZO-1 and 
ZO-2 colocalized in endothe- 
lia of blood vessels (arrows). 
ZO-1  staining was  uniquely 
observed in intercalated discs 
of  myocytes (arrowheads). 
Bar, 20/~m. 
95/SAP90, a synapse-associated protein from rat brain. The 
homology between ZO-2 and these proteins was displayed 
within discrete domains shared among all family members, 
including an internal repeat (DHR) of  unknown function and 
a  region  resembling  yeast  guanylate kinase,  an  enzyme 
which converts 5'-GMP to GTP.  Taken together, the close 
relationship displayed with ZO-1 and the sequence homology 
shared with other discs-large family members indicates that 
ZO-2 is a member of the discs-large family of proteins. The 
roles of ZO-2, ZO-1, PSD-95/SAP90, and p55 have not yet 
been elucidated. Mutations in the dig gene have been shown 
to result in neoplastic over-growth of imaginal discs of Dro- 
sophila larvae, suggesting that the dlg gene product acts as 
a tumor suppressor. Though it is not yet known how the dig 
product carries out this function, both the guanylate kinase 
and amino-terminal regions are important for its tumor sup- 
pressing activity (Woods and Bryant, 1989, 1991). 
Northern analysis reveals an mRNA size of ,,05.2 kb, dis- 
tinct from the 7.9-kb message for ZO-1. Our 3.2 kb of cloned 
ZO-2  eDNA  contains 2325  bp  of coding and 875  bp  of 
3'-untranslated eDNA.  Thus,  there are roughly 2.0 kb of 
missing 5' eDNA from our isolate. Since SDS gels reveal an 
Mr ~  160 kD for ZO-2, most of this missing 5' eDNA must 
be coding, with very little 5'-untranslated sequence. 
SH3 domains have been shown to bind to proline-rich se- 
quences (Ren et al., 1993). The proline-rich carboxyl termi- 
nus of ZO-2 together with the presence of an SH3-1ike do- 
main in ZO-1, may offer an explanation for the association 
between these two proteins. Alternatively, it is possible that 
formation of ZO-2/ZO-1 complexes is mediated by the inter- 
action of putative leucine zipper regions contained in these 
two proteins, since this motif has been shown to be both 
necessary and  sufficient for heterodimerization of DNA- 
binding proteins  (Baxevanis  and Vinson,  1993).  Another 
function which has been demonstrated for SH3 domains is 
the targeting of proteins to specific subeellular localizations 
(Bar-Sagi et al.,  1993).  Thus SH3 domains in ZO-2/ZO-1 
complexes may be responsible for localization of these pro- 
teins to tight junctions. 
From the sequence comparison of ZO-2 with ZO-1, it was 
not possible to determine whether ZO-2 also contained an 
alternatively spliced c~-motif. Since we have only one eDNA 
isolate,  we also have no evidence for alternative splicing 
from our DNA  sequence data.  Immunoblotting of whole 
MDCK cell extracts with the R9989 anti-ZO-2 polyclonal 
antibody revealed a doublet at 160 kD, as well as a slower 
migrating band at 190 kD (Fig. 5), suggesting that these cells 
may synthesize alternative forms of ZO-2. Recognition of  the 
Jesaitis and Goodenough Characterization of ZO-2  959 160-kD doublet and 190-kD band by a second anti-ZO-2 an- 
tiserum,  GP  753,  raised in guinea pig  (data  not  shown), 
lends support  to the notion that these bands are related to 
ZO-2. In blots of ZO-1/ZO-2 coimmunoprecipitates (Fig. 5) 
only a single band comigrating with the lower band of the 
160-kD doublet was observed, raising the interesting possi- 
bility that ZO-1 associates exclusively with one of several al- 
ternative  ZO-2 species. 
Cytoplasmic staining was observed with R9989 in MDCK 
cell monolayers which was not seen in cryosections of in situ 
epithelia.  The cytoplasmic staining, which was inhibitable 
with immunizing polypeptide, could indicate the presence of 
cytoplasmic pools of ZO-2 not seen in other tissues. Alterna- 
tively,  immunoprecipitation  of MDCK  cell  extracts  with 
R9989 yielded additional polypeptides at Mr ~  180 and 240 
kD not seen in immunoprecipitates of identical extracts with 
either R40.76  (anti-ZO-1 monoclonal) or with the anti-ZO-2 
guinea-pig serum GP 753 (data not shown). Taken together, 
these results suggest that our R9989 reagent immunoprecipi- 
tates additional polypeptides in the MDCK cell, whose loca- 
tion is currently  unknown. Thus it is not clear if the cyto- 
plasmic staining  observed in MDCK  cells corresponds to 
cytoplasmic ZO-2, or if it corresponds to the cross-reacting 
species. 
Itoh et ai. (1993) have previously shown that ZO-I local- 
izes to the fascia adherens component of intercalated  discs 
joining myocardial cells. The results presented here confirm 
the presence of ZO-1 immunoreactivity in intercalated  discs 
by immunofluorescence microscopy.  In contrast,  ZO-2 stain- 
ing was detected only in blood vessel endothelia in heart, 
suggesting that this protein is not associated with the fasciae 
adhaerentes of the intercalated  discs. At the ultrastructural 
level, ZO-2 immunogold labeling was associated exclusively 
with tight junctions in MDCK epithelial cells. We did not ob- 
serve ZO-2 or ZO-1  staining of the other members of the 
junctional complex, the zonulae adhaerentes and maculae 
adhaerentes, in these preparations. 
ZO-2 and ZO-1 thus appear to be obligate partners at the 
cytoplasmic  surfaces  of vertebrate  tight  junctions  while 
ZO-1 localizes, in the absence of ZO-2, at the myocardial in- 
tercalated  disc. It will be of interest to investigate whether 
a related family member, the product of the dig gene in Dro- 
sophila,  also has an obligate partner in the structure of the 
septate junction. The tumor suppressor activity exhibited by 
the product of the dig gene in insect imaginal disc epithelial 
cells  raises  the  additional  question  as  to  whether ZO-2, 
ZO-1,  or  both  proteins  share  this  activity  in  vertebrate 
epithelia. 
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